Cargando…
Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy
Periplocymarin (PPM), a cardiac glycoside, has a narrow therapeutic index, poor tumor selectivity and severe cardiovascular toxicity which hinder its wide clinical applications in cancer treatment. Herein, we report novel redox-responsive prodrug-nanoparticles (MPSSV-NPs) self-assembled by co-nanopr...
Autores principales: | Zhang, Huiyun, Xu, Wenqian, Omari-Siaw, Emmanuel, Liu, Yingkun, Chen, Baoding, Chen, Deyu, Yu, Jiangnan, Xu, Ximing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241199/ https://www.ncbi.nlm.nih.gov/pubmed/28835137 http://dx.doi.org/10.1080/10717544.2017.1365393 |
Ejemplares similares
-
Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome
por: Zhang, Huiyun, et al.
Publicado: (2022) -
Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation
por: Zhang, Hui-Yun, et al.
Publicado: (2016) -
Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy
por: Chang, Sheng, et al.
Publicado: (2019) -
In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
por: Schumacher, Felix F., et al.
Publicado: (2011) -
Periplocymarin Alleviates Doxorubicin-Induced Heart Failure and Excessive Accumulation of Ceramides
por: Yun, Weijing, et al.
Publicado: (2021)